Insider Transactions in Q2 2024 at West Pharmaceutical Services Inc (WST)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2024
|
Silji Abraham SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,800
-38.63%
|
$594,000
$330.78 P/Share
|
|
May 10
2024
|
Thomas W Hofmann Director |
SELL
Open market or private sale
|
Direct |
617
-1.4%
|
$225,205
$365.92 P/Share
|
|
May 07
2024
|
Eric Mark Green President, CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+8.64%
|
$4,350,000
$58.51 P/Share
|
|
May 07
2024
|
Eric Mark Green President, CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
66,000
-10.96%
|
$24,156,000
$366.65 P/Share
|
|
Apr 23
2024
|
Paolo Pucci Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+5.4%
|
-
|
|
Apr 23
2024
|
Goldman Myla Lai Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+2.98%
|
-
|
|
Apr 23
2024
|
Douglas A Michels Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+1.26%
|
-
|
|
Apr 23
2024
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+25.66%
|
-
|
|
Apr 23
2024
|
Deborah L Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+5.56%
|
-
|
|
Apr 23
2024
|
Robert F Friel Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+13.51%
|
-
|
|
Apr 23
2024
|
Molly Joseph Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+23.74%
|
-
|
|
Apr 23
2024
|
Mark A Buthman Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+1.33%
|
-
|
|
Apr 23
2024
|
William F Feehery Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+1.83%
|
-
|
|
Apr 23
2024
|
Thomas W Hofmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+1.26%
|
-
|